Blog Testimonial

Enterosgel PUBMED Clinically Proven Publications

Enterosgel Clinically Proven

Enterosgel well known anti-toxins gastro-absorbent.

To see publications please follow the link PUBMED Enterosgel


Please rate this information
  • 0/5
  • 0 ratings
0 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 0%
Read More

Medsilica-Promobot Artificial Intelligent Robots

New Zealand welcomes Artificial Intelligent Robots

The Medsilica Group is the first company in the Pacific Region to employ Artificial Intelligent Robots.

According to Dr.Vladimir Milushkin, Medsilica Group’s CEO, – “We believe, our Artificial Intelligent Robots will create many new jobs in New Zealand and Australia”.

The company’s plan is to launch this type of  machine in Australia at the end of this year.

The Medsilica-Promobot Artificial Intelligent Robots are used in many fields: Airports, Security , Banks, Universities, Insurance companies, Councils, Museums, etc.


Please rate this information
  • 5/5
  • 3 ratings
3 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

Medsilica-Enterosgel Free Protection

Protection for the Whole Family

What does it mean Medsilica-Enterosgel Protection?

Enterosgel Protection is a way to insure our customers that all investments (spending’s) in Enterosgel would value for all families in New Zealand and Australia. We insure our customers that all unopened Enterosgel tubes will be replaced for another 3 years protection without any extra payment. We wish that our customers would never regret investing money to Enterosgel Protection.

This is our next step to say THANK YOU to all our loyal customers.


Please rate this information
  • 5/5
  • 2 ratings
2 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

ENTEROSGEL HAS BEEN TESTED BY ACCREDITED SPORTS ANTI-DOPING LABORATORY

Enterosgel, batch #L309170051, has been tested by the Britain National Measurement Laboratory and Designated Institute (LGC) for a wide range of substances banned by WADA (the World Anti Doping Agency) to provide the highest level of assurance that they are safer for athletes to use.

LGC is a World Class sports doping control and research laboratory, with more than 50 years of leadership in drug surveillance in sport.

Ryan Bellone | Business Development Manager | Sport and Specialized Analytical Services | Standards | Mobile: +1 206-452-4948 | ryan.bellone@lgcgroup.com | Skype: lgc.ryan.bellone |
LGC Lexington | 1745 Alysheba Way, Suite 160 | Lexington | Kentucky | 40509 | USA |
LGC Fordham | Newmarket Road | Fordham | Cambridgeshire | CB7 5WW | UK |
informed-choice.org | informed-sport.com | lgcgroup.com


Please rate this information
  • 5/5
  • 1 rating
1 ratingX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

Treatment with antibiotics must necessarily be accompanied by the prescription of enterosorbents.

 

New medical publication is available for professionals

Irrespective of the type of diarrhoea, probiotics, enterosorbents and medications of immunomodulatory action should be considered alternative to antibiotics and chemotherapeutic agents for starting etiotropic therapy of mild, moderate, even severe forms of Acute intestinal infections in children (under condition of starting treatment on day 1-2 of the disease).


Please rate this information
  • 5/5
  • 1 rating
1 ratingX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

ENTEROSGEL IS REGISTERED IN AUSTRALIA

Congratulation!

After 3 years debates, Department of Health and Therapeutic Goods approved to supply Enterosgel- Mineral-based gastrointestinal detoxifier to Australia.

Intended Use
Enterosgel is an intestinal absorbent (enterosorbent) intended to be used as an adjuvant to standard rehydration therapy and in the management and reduction of stomach and intestinal illness symptoms.


Please rate this information
  • 5/5
  • 3 ratings
3 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

A new translation of Scientific Publication for Professionals is available.

ALLERGOLOGY AND DERMATOLOGY
Modern pediatrics 3 (37) / 2011

FORECASTING HEALTH STATUS OF CHILDREN WITH EARLIEST MANIFESTATIONS OF ATOPIC DERMATITIS

T.L. Protsyuk, N.I. Tocarchuk, L.A. Protsyuk, О. V. Chirkа, N.M. Surkovа, L.D. Kotsur
National Pirogov Memorial Medical University,  Vinnytsya Regional Children’s Clinical Hospital

MATERIAL AND METHODS OF THE STUDY
90 infants in the first year of life with severe (45 patients) and moderate (45 patients) atopic dermatitis (group 1) and 50 patients in the first year of life with mild forms of atopic dermatitis – (group 2) were examined. Follow-ups of children were carried out during 4 years.


Please rate this information
  • 5/5
  • 1 rating
1 ratingX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

THE SECRET OFFER

from Exclusive Distributor of Enterosgel in New Zealand & Australia

Please rate this information
  • 5/5
  • 2 ratings
2 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More